Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607

Watchlist Manager
Shanghai Pharmaceuticals Holding Co Ltd Logo
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Watchlist
Price: 18.24 CNY -0.33% Market Closed
Market Cap: 51.9B CNY
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one Shanghai Pharmaceuticals Holding Co Ltd stock under the Base Case scenario is 70.99 CNY. Compared to the current market price of 18.24 CNY, Shanghai Pharmaceuticals Holding Co Ltd is Undervalued by 74%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
70.99 CNY
Undervaluation 74%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.2
P/S
P/S
Price to Sales
0.2
vs History
95
vs Industry
88
Median 3Y
0.2
Median 5Y
0.2
Industry
2.2
Forward
0.2
More Details
11.4
P/E
P/E
Price to Earnings
11.4
vs History
52
vs Industry
35
Median 3Y
11.7
Median 5Y
11.6
Industry
21.8
Forward
10.1
More Details
8.9
P/OCF
P/OCF
Price to OCF
8.9
vs History
73
vs Industry
37
Median 3Y
11.4
Median 5Y
10.1
Industry
13.4
More Details
7.2
P/FCFE
P/FCFE
Price to FCFE
7.2
vs History
69
vs Industry
34
Median 3Y
8.7
Median 5Y
8.9
Industry
19
More Details
0.7
P/B
P/B
Price to Book Value
0.7
vs History
92
vs Industry
70
Median 3Y
0.8
Median 5Y
0.9
Industry
2.1
More Details
0.3
EV/S
EV/S
Enterprise Value to Sales
0.3
vs History
63
vs Industry
86
Median 3Y
0.3
Median 5Y
0.3
Industry
2.3
Forward
0.2
More Details
2.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
2.4
vs History
36
vs Industry
64
Median 3Y
2.2
Median 5Y
2.4
Industry
4.8
More Details
8.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
8.1
vs History
44
vs Industry
36
Median 3Y
7.8
Median 5Y
8
Industry
11.4
Forward
5.8
More Details
8.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
8.1
vs History
44
vs Industry
40
Median 3Y
7.8
Median 5Y
8
Industry
15.5
Forward
6.9
More Details
12.8
EV/OCF
EV/OCF
Enterprise Value to OCF
12.8
vs History
52
vs Industry
31
Median 3Y
14.2
Median 5Y
13
Industry
13.3
More Details
21.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
21.8
vs History
47
vs Industry
20
Median 3Y
21.8
Median 5Y
21.4
Industry
17.1
More Details
0.6
EV/IC
EV/IC
Enterprise Value to IC
0.6
vs History
57
vs Industry
74
Median 3Y
0.6
Median 5Y
0.6
Industry
1.8
More Details

Multiples Across Competitors

Competitors Multiples
Shanghai Pharmaceuticals Holding Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
51.9B CNY 0.2 11.4 8.1 8.1
US
Mckesson Corp
NYSE:MCK
87.6B USD 0.3 31 18.4 21.1
US
Cencora Inc
NYSE:COR
55.4B USD 0.2 39.7 13.9 19
US
Amerisourcebergen Corp
LSE:0HF3
54.9B USD 0.2 39.3 13.8 18.8
US
Cardinal Health Inc
NYSE:CAH
33.3B USD 0.1 25.4 12.2 16.1
AU
Sigma Healthcare Ltd
ASX:SIG
34.7B AUD 7.1 -2 510.2 1 609.3 1 609.3
CN
Huadong Medicine Co Ltd
SZSE:000963
66B CNY 1.6 18.8 15 15
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW 5.9 89.6 59.9 61.9
AU
EBOS Group Ltd
OTC:EBOSY
8.2B USD 1 51.9 30.9 30.9
US
Henry Schein Inc
NASDAQ:HSIC
8.1B USD 0.6 20.7 10.1 14.2
CN
Sinopharm Group Co Ltd
HKEX:1099
54.4B HKD 0.1 7.2 0.4 0.5

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 249,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.